Chemical Compound
Saquinavir mesylate
CAS Registry Number
149845-06-7
Primary Record
Saquinavir mesylate
- In stock
- 1,877 g
- Purity
- 98.5 %
- CAS
- 149845-06-7
Compound Identifiers & Properties
- CAS
- 149845-06-7
- PubChem CID
- 60934
- SMILES
- CC(C)(C)NC(=O)[C@@H]1C[C@@H]2CCCC[C@@H]2CN1C[C@H]([C@H](CC3=CC=CC=C3)NC(=O)[C@H](CC(=O)N)NC(=O)C4=NC5=CC=CC=C5C=C4)O.CS(=O)(=O)O
- Canonical SMILES
- CC(C)(C)NC(=O)[C@@H]1C[C@@H]2CCCC[C@@H]2CN1C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(N)=O)NC(=O)c1ccc2ccccc2n1.CS(=O)(=O)O
Names & Synonyms
- Saquinavir mesylate
- Invirase
- Fortovase
- Saquinavir mesilate
- 149845-06-7
- Saquinavir, Mesylate
- Invirase (TN)
- Saquinavir (Mesylate)
- Saquinavir Mesylate?
- SAQUINAVIR
- 6-Bromonicotinaldehyde
- Saquinavir mesilate RS
- Saquinavir mesylate [USAN]
- UNII-UHB9Z3841A
- Saquinavir mesilate CRS
- SAQUINAVIRMESYLATE
- RefChem:57421
- Ro 31-8959/003
- Saquinavir methanesulfonate salt
- UHB9Z3841A
- DTXSID9023835
- Saquinavir mesilate (JAN)
- Saquinavir mesylate (USP)
- Saquinavir monomethanesulfonate salt
- AC1L1U6R
- DTXCID803835
- SCHEMBL42352
- MLS001401395
- Saquinavir mesylate [USAN:USP]
- Saquinavir Monomethanesulfonate
- IRHXGOXEBNJUSN-YOXDLBRISA-N
- MFCD00944907
- CHEMBL282042
- SCHEMBL29362141
- SCHEMBL29403886
- 6-bromopyridine-3-carboxaldehyde
- C39H54N6O8S
- CHEBI:32121
- CTK8E9063
- Saquinavir mesylate (USAN:USP)
- AOB1668
- SAQUINAVIR MESILATE [JAN]
- C38H50N6O5.CH4O3S
- Saquinavir (mesylate) (Standard)
- C38H50N6O5
- GLXC-02559
- HMS1571O10
- HMS2051D04
- HMS2098O10
- HMS2231C15
- HMS3715O10
- 149845-06-7 (mesylate)
- Ro-31-8959/003
- Saquinavir mesylate (AIDS Initiative)
- SAQUINAVIR MESYLATE [VANDF]
- CID60934
- DRG-0164
- SAQUINAVIR MESILATE (MART.)
- SAQUINAVIR MESILATE [MART.]
- Ro-318959003
- Tox21_111137
- Tox21_202533
- HY-17003R
- LS-872
- NCGC00091469-01
- Ro 31-8959
- SAQUINAVIR MESILATE [WHO-DD]
- SAQUINAVIR MESILATE [WHO-IP]
- SAQUINAVIR MESYLATE (USP-RS)
- SAQUINAVIR MESYLATE [USP-RS]
- Saquinavir for system suitability CRS
- AKOS015962362
- AC-1333
- ACN-043391
- CCG-100992
- EBC-102160
- FS27793
- KS-1110
- NC00242
- Saquinavir mesylate - Bio-X trade mark
- NCGC00260082-01
- Ro-31-8959
- SAQUINAVIR MESYLATE [ORANGE BOOK]
- AN-15024
- BC680513
- BS164392
- CPD000469290
- R-56
- SAM001246578
- SAQUINAVIR MESILATE (EP MONOGRAPH)
- SAQUINAVIR MESILATE [EP MONOGRAPH]
- SAQUINAVIR MESYLATE (USP IMPURITY)
- SAQUINAVIR MESYLATE [USP IMPURITY]
- SMR000469290
- SAQUINAVIR MESYLATE (USP MONOGRAPH)
- SAQUINAVIR MESYLATE [USP MONOGRAPH]
- RT-015634
- C38-H50-N6-O5.C-H4-O3-S
- CAS-149845-06-7
- FT-0631179
- SAQUINAVIR METHANESULFONATE SALT [MI]
- Ro-31-8959-003
- Saquinavir mesylate, >=98% (HPLC), powder
- A12071
- C12560
- D01160
- F84902
- W-5240
- Butanediamide, N1-[(1S,2R)-3-[(3S,4aS,8aS)-3-[[(1,1-dimethylethyl)amino]carbonyl]octahydro-2(1H)-isoquinolinyl]-2-hydroxy-1-(phenylmethyl)propyl]-2-[(2-quinolinylcarbonyl)amino]-, (2S)-, methanesulfonate (1:1)
- 845S067
- A884226
- SR-01000763454
- (S)-N1-((2S,3R)-4-((3S,4aS,8aS)-3-(tert-butylcarbamoyl)octahydroisoquinolin-2(1H)-yl)-3-hydroxy-1-phenylbutan-2-yl)-2-(quinoline-2-carboxamido)succinamide methanesulfonate
- SR-01000763454-4
- Q27114794
- (2S)-N-[(2S,3R)-4-[(3S,4aS,8aS)-3-(tert-butylcarbamoyl)-3,4,4a,5,6,7,8,8a-octahydro-1H-isoquinolin-2-yl]-3-hydroxy-1-phenylbutan-2-yl]-2-(quinoline-2-carbonylamino)butanediamide;methanesulfonic acid
- B2693-059341
- (S)-N-((alphaS)-alpha-((1R)-2-((3S,4aS,8aS)-3-(tert-Butylcarbamoyl)octahydro-2(1H)-isoquinolyl)-1-hydroxyethyl)phenethyl)-2-quinaldamidosuccinamide monomethanesulfonate (salt)
- Butanediamide, N1-((1S,2R)-3-((3S,4aS,8aS)-3-(((1,1-dimethylethyl)amino)carbonyl)octahydro-2(1H)-isoquinolinyl)-2-hydroxy-1-(phenylmethyl)propyl)-2-((2-quinolinylcarbonyl)amino)-, (2S)-, monomethanesulfonate (salt)
- SQV
- Saquinavir mesilate, European Pharmacopoeia (EP) Reference Standard
- (2S)-N1[(1S,2R)-3-[(3S,4aS,8aS)-3-[[(1,1-Dimethylethyl)amino]carbonyl]octahydro-2-(1H)-isoquinolinyl]-2-hydroxy-1-(phenylmethyl)propyl]-2-[(2-quinolinylcarbonyl)amino]butanediamide Mesylate
- Butanediamide, N(sup 1)-(3-(3-(((1,1-dimethylethyl)amino)carbonyl)octahydro-2(1H)-isoquinolinyl)-2-hydroxy-1-(phenylmethyl)propyl)-2-((2-quinolinylcarbonyl)amino)-, (3S-(2(1R*(R*),2S*),3alpha,4abeta,8abeta))-, monomethanesulfonate (salt)
- Saquinavir mesylate, United States Pharmacopeia (USP) Reference Standard
- 2-[[2-METHYL-3-(TRIFLUOROMETHYL)PHENYL]AMINO]PYRIDINE-3-CARBOXYLIC ACID MESYLATE
- Saquinavir for system suitability, European Pharmacopoeia (EP) Reference Standard
- (2S)-N-[(1S,2R)-3-[(3S,4aS,8aS)-3-(tert-butylcarbamoyl)-3,4,4a,5,6,7,8,8a-octahydro-1H-isoquinolin-2-yl]-1-benzyl-2-hydroxy-propyl]-2-(quinoline-2-carbonylamino)butanediamide; methanesulfonic acid
- (2S)-N-[(1S,2R)-3-[(3S,4aS,8aS)-3-(tert-butylcarbamoyl)-3,4,4a,5,6,7,8,8a-octahydro-1H-isoquinolin-2-yl]-1-benzyl-2-hydroxy-propyl]-2-(quinoline-2-carbonylamino)butanediamide;methanesulfonic acid
- (2S)-N-[(2S,3R)-4-[(3S,4aS,8aS)-3-(tert-butylcarbamoyl)-3,4,4a,5,6,7,8,8a-octahydro-1H-isoquinolin-2-yl]-3-hydroxy-1-phenylbutan-2-yl]-2-(quinoline-2-carbonylamino)butanediamide methanesulfonate
- (2S)-N-[(2S,3R)-4-[(3S,4aS,8aS)-3-(tert-butylcarbamoyl)-3,4,4a,5,6,7,8,8a-octahydro-1H-isoquinolin-2-yl]-3-hydroxy-1-phenylbutan-2-yl]-2-(quinoline-2-carbonylamino)butanediamide; methanesulfonic acid
- (2S)-N1-[(1S,2R)-3-[(3S,4aS,8aS)-3-[[(1,1-dimethylethyl)amino]carbonyl]octahydro-2(1H)-isoquinolinyl]-2-hydroxy-1-(phenylmethyl)propyl]-2-[(2-quinolinylcarbonyl)amino]butanediamide methanesulfonate
- (2S)-N1[(1S,2R)-3-[(3S,4aS,8aS)-3-[[(1,1-Dimethylethyl)amino]carbonyl]octahydro-2(1H)-isoquinolinyl]-2-hydroxy-1-(phenylmethyl)propyl]-2-[(2-quinolinylcarbonyl)amino]butanediamide methanesulfonate
- (S)-N-((.ALPHA.S)-.ALPHA.-((1R)-2-((3S,4AS,8AS)-3-(TERT-BUTYLCARBAMOYL)OCTAHYDRO-2(1H)-ISOQUINOLYL)-1-HYDROXYETHYL)PHENETHYL)-2-QUINALDAMIDOSUCCINAMIDE MONOMETHANESULFONATE
- (S)-N-((.ALPHA.S)-.ALPHA.-((1R)-2-((3S,4AS,8AS)-3-(TERT-BUTYLCARBAMOYL)OCTAHYDRO-2(1H)-ISOQUINOLYL)-1-HYDROXYETHYL)PHENETHYL)-2-QUINALDAMIDOSUCCINAMIDE MONOMETHANESULPHONATE
- (S)-N-((alphaS)-alpha-((1R)-2-((3S,4AS,8AS)-3-(TERT-BUTYLCARBAMOYL)OCTAHYDRO-2(1H)-ISOQUINOLYL)-1-HYDROXYETHYL)PHENETHYL)-2-QUINALDAMIDOSUCCINAMIDE MONOMETHANESULFONATE
- (S)-N-((alphaS)-alpha-((1R)-2-((3S,4AS,8AS)-3-(TERT-BUTYLCARBAMOYL)OCTAHYDRO-2(1H)-ISOQUINOLYL)-1-HYDROXYETHYL)PHENETHYL)-2-QUINALDAMIDOSUCCINAMIDE MONOMETHANESULPHONATE
- (S)-N-((alphaS)-alpha-((1R)-3S,4aS,8aS)-3-(tert-Butylcarbaoyl)octahydro-2(1H)-isoquinolyl)-1-hydroxyethyl)phenethyl)-2-quinaldamidosuccinam ide monomethanesulfonate (salt)
- 127779-20-8
- BUTANEDIAMIDE, N(SUP 1)-(3-(3-(((1,1-DIMETHYLETHYL)AMINO)CARBONYL)OCTAHYDRO-2(1H)-ISOQUINOLINYL)-2-HYDROXY-1-(PHENYLMETHYL)PROPYL)-2-((2-QUINOLINYLCARBONYL)AMINO)-, (3S-(2(1R*(R*),2S*),3.ALPHA.,4A.BETA.,8A.BETA.))-, MONOMETHANESULFONATE
- BUTANEDIAMIDE, N(SUP 1)-(3-(3-(((1,1-DIMETHYLETHYL)AMINO)CARBONYL)OCTAHYDRO-2(1H)-ISOQUINOLINYL)-2-HYDROXY-1-(PHENYLMETHYL)PROPYL)-2-((2-QUINOLINYLCARBONYL)AMINO)-, (3S-(2(1R*(R*),2S*),3.ALPHA.,4A.BETA.,8A.BETA.))-, MONOMETHANESULPHONATE
- BUTANEDIAMIDE, N(SUP 1)-(3-(3-(((1,1-DIMETHYLETHYL)AMINO)CARBONYL)OCTAHYDRO-2(1H)-ISOQUINOLINYL)-2-HYDROXY-1-(PHENYLMETHYL)PROPYL)-2-((2-QUINOLINYLCARBONYL)AMINO)-, (3S-(2(1R*(R*),2S*),3alpha,4Abeta,8Abeta))-, MONOMETHANESULFONATE
- BUTANEDIAMIDE, N(SUP 1)-(3-(3-(((1,1-DIMETHYLETHYL)AMINO)CARBONYL)OCTAHYDRO-2(1H)-ISOQUINOLINYL)-2-HYDROXY-1-(PHENYLMETHYL)PROPYL)-2-((2-QUINOLINYLCARBONYL)AMINO)-, (3S-(2(1R*(R*),2S*),3alpha,4Abeta,8Abeta))-, MONOMETHANESULPHONATE
- Methanesulfonic acid--N~1~-{(2S,3R)-4-[(3S,4aS,8aS)-3-(tert-butylcarbamoyl)octahydroisoquinolin-2(1H)-yl]-3-hydroxy-1-phenylbutan-2-yl}-N~2~-(quinoline-2-carbonyl)-L-aspartamide (1/1)
- N-t-butyl-decahydro-2-[2(R)-hydroxy-4-phenyl-3(S)-[[N-(2-quinolylcarbonyl)-L-asparaginyl]amino]butyl]-(4aS,8aS)-isoquinoline-3(S)-carboxamide methanesulphonate
- Saquinavir mesilate; (2S)-N1-[(1S,2R)-1-Benzyl-3-[(3S,4aS,8aS)-3-[(1,1-dimethylethyl)carbamoyl]octahydroisoquinolin-2(1H)-yl]-2-hydroxypropyl]-2-[(quinolin-2-ylcarbonyl)amino]butanediamide methanesulfonate; Butanediamide, N1-[(1S,2R)-3-[(3S,4aS,8aS)-3-[[(1,1-dimethylethyl)amino]carbonyl]octahydro-2(1H)-isoquinolinyl]-2-hydroxy-1-(phenylmethyl)propyl]-2-[(2-quinolinylcarbonyl)amino]-, (2S)-, methanesulfonate (1:1); Butanediamide, N1-[(1S,2R)-3-[(3S,4aS,8aS)-3-[[(1,1-dimethylethyl)amino]carbonyl]octahydro-2(1H)-isoquinolinyl]-2-hydroxy-1-(phenylmethyl)propyl]-2-[(2-quinolinylcarbonyl)amino]-, (2S)-, monomethanesulfonate (salt) (9CI); Invirase; Ro 31-8959/003; Saquinavir mesylate; Butanediamide, N1-[3-[3-[[(1,1-dimethylethyl)amino]carbonyl]octahydro-2(1H)-isoquinolinyl]-2-hydroxy-1-(phenylmethyl)propyl]-2-[(2-quinolinylcarbonyl)amino]-, [3S-[2[1R*(R*),2S*],3alpha,4abeta,8abeta]]-, monometha